Literature DB >> 26136871

Novel heterozygous mutation c.4282G>T in the SCN5A gene in a family with Brugada syndrome.

Jian-Fang Zhu1, Li-Li DU2, Yuan Tian3, Yi-Mei DU2, Ling Zhang2, Tao Zhou4, L I Tian5.   

Abstract

Brugada syndrome (BrS) is a rare, inherited arrhythmia syndrome. The most well-known gene that is responsible for causing BrS is SCN5A, which encodes the human cardiac Na+ channel (Nav1.5) α subunit. To date, it has been reported that >100 mutations in SCN5A can cause BrS. In the present study, a novel BrS-associated Nav1.5 mutation, A1428S, was identified in a proband who was successfully resuscitated from an episode of sudden collapse during walking. This mutation was further confirmed by polymerase chain reaction (PCR)-restriction fragment length polymorphism analysis, which showed that the PCR fragment containing the mutation A1428S could be cut by the restriction enzyme Nsi1, yielding two shorter DNA fragments of 329 and 159 bp, which were not present in family members homozygous for the wild-type (WT) allele. Furthermore, the electrophysiological properties were analyzed by patch clamp technique. Current density was decreased in the A1428S mutant compared that in the WT. However, neither the steady-state activation or inactivation, nor the recovery from inactivation exhibited changes between the A1428S mutant and the WT. In conclusion, the results of this study are consistent with the hypothesis that a reduction in Nav1.5 channel function is involved in the pathogenesis of BrS. The structural-functional study of the Nav1.5 channel enhances the present understanding the pathophysiological function of the channel.

Entities:  

Keywords:  Brugada syndrome; SCN5A; heterozygous mutation

Year:  2015        PMID: 26136871      PMCID: PMC4471719          DOI: 10.3892/etm.2015.2361

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  37 in total

Review 1.  Proposed diagnostic criteria for the Brugada syndrome: consensus report.

Authors:  Arthur A M Wilde; Charles Antzelevitch; Martin Borggrefe; Josep Brugada; Ramón Brugada; Pedro Brugada; Domenico Corrado; Richard N W Hauer; Robert S Kass; Koonlawee Nademanee; Silvia G Priori; Jeffrey A Towbin
Journal:  Circulation       Date:  2002-11-05       Impact factor: 29.690

Review 2.  Brugada syndrome: report of the second consensus conference.

Authors:  Charles Antzelevitch; Pedro Brugada; Martin Borggrefe; Josep Brugada; Ramon Brugada; Domenico Corrado; Ihor Gussak; Herve LeMarec; Koonlawee Nademanee; Andres Ricardo Perez Riera; Wataru Shimizu; Eric Schulze-Bahr; Hanno Tan; Arthur Wilde
Journal:  Heart Rhythm       Date:  2005-04       Impact factor: 6.343

3.  Tubulin polymerization modifies cardiac sodium channel expression and gating.

Authors:  Simona Casini; Hanno L Tan; Ilker Demirayak; Carol Ann Remme; Ahmad S Amin; Brendon P Scicluna; Houssine Chatyan; Jan M Ruijter; Connie R Bezzina; Antoni C G van Ginneken; Marieke W Veldkamp
Journal:  Cardiovasc Res       Date:  2009-10-26       Impact factor: 10.787

4.  Functional effects of KCNE3 mutation and its role in the development of Brugada syndrome.

Authors:  Eva Delpón; Jonathan M Cordeiro; Lucía Núñez; Poul Erik Bloch Thomsen; Alejandra Guerchicoff; Guido D Pollevick; Yuesheng Wu; Jørgen K Kanters; Carsten Toftager Larsen; Jacob Hofman-Bang; Elena Burashnikov; Michael Christiansen; Charles Antzelevitch
Journal:  Circ Arrhythm Electrophysiol       Date:  2008-08

5.  Role of HCN4 channel in preventing ventricular arrhythmia.

Authors:  Kazuo Ueda; Yuji Hirano; Yasushi Higashiuesato; Yoshiyasu Aizawa; Takeharu Hayashi; Natsuko Inagaki; Takeshi Tana; Yusuke Ohya; Shuichi Takishita; Hiromi Muratani; Masayasu Hiraoka; Akinori Kimura
Journal:  J Hum Genet       Date:  2009-01-23       Impact factor: 3.172

6.  Natural history of Brugada syndrome: insights for risk stratification and management.

Authors:  Silvia G Priori; Carlo Napolitano; Maurizio Gasparini; Carlo Pappone; Paolo Della Bella; Umberto Giordano; Raffaella Bloise; Carla Giustetto; Roberto De Nardis; Massimiliano Grillo; Elena Ronchetti; Giovanna Faggiano; Janni Nastoli
Journal:  Circulation       Date:  2002-03-19       Impact factor: 29.690

7.  SCN5A mutations in Brugada syndrome are associated with increased cardiac dimensions and reduced contractility.

Authors:  Frans van Hoorn; Maria E Campian; Anje Spijkerboer; Marieke T Blom; R Nils Planken; Albert C van Rossum; Jacques M T de Bakker; Arthur A M Wilde; Maarten Groenink; Hanno L Tan
Journal:  PLoS One       Date:  2012-08-02       Impact factor: 3.240

8.  Mexiletine differentially restores the trafficking defects caused by two brugada syndrome mutations.

Authors:  Adrien Moreau; Dagmar I Keller; Hai Huang; Véronique Fressart; Christian Schmied; Quadiri Timour; Mohamed Chahine
Journal:  Front Pharmacol       Date:  2012-04-20       Impact factor: 5.810

9.  A review of the mechanisms of ventricular arrhythmia in brugada syndrome.

Authors:  J Bhar-Amato; Lm Nunn; Pd Lambiase
Journal:  Indian Pacing Electrophysiol J       Date:  2010-09-05

Review 10.  Cardiac sodium channelopathies.

Authors:  Ahmad S Amin; Alaleh Asghari-Roodsari; Hanno L Tan
Journal:  Pflugers Arch       Date:  2009-11-29       Impact factor: 3.657

View more
  3 in total

1.  [Functional analysis of a novel SCN5A mutation G1712C identified in Brugada syndrome].

Authors:  Yan-Yu Chen; Shen-Rong Liu; Liang-Zhen Xie; Ting-Yan Zhu; Yi-Zhen Chen; Xiao-Jiang Deng; Su-Rong Meng; Jian Peng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2016-02-20

Review 2.  Dysfunctional Nav1.5 channels due to SCN5A mutations.

Authors:  Dan Han; Hui Tan; Chaofeng Sun; Guoliang Li
Journal:  Exp Biol Med (Maywood)       Date:  2018-05-27

3.  Novel SCN5A variants identified in a group of Iranian Brugada syndrome patients.

Authors:  Taraneh Ghaffari; Naser Mirhosseini Motlagh; Abdolreza Daraei; Majid Tafrihi; Mehrdad Saravi; Davood Sabour
Journal:  Funct Integr Genomics       Date:  2021-02-27       Impact factor: 3.410

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.